Andrea Frilling

Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial

Gunnar Folprecht, Thomas Gruenberger, Wolf O. Bechstein et al. · The Lancet Oncology · 2009 · 960 citations

Medicine, Oncology, Chemotherapy +16

Specific mutations of the RET proto-oncogene are related to disease phenotype in MEN 2A and FMTC

Lois M. Mulligan, Charis Eng, Catherine S. Healey et al. · Nature Genetics · 1994 · 651 citations

Life Sciences, Genetics, Molecular Genetics +16

Response to radiofrequency ablation of pulmonary tumours: a prospective, intention-to-treat, multicentre clinical trial (the RAPTURE study)

Riccardo Lencioni, Laura Crocetti, Roberto Cioni et al. · The Lancet Oncology · 2008 · 528 citations

Medicine, Oncology, Surgery +7

A Limited Set of Human MicroRNA Is Deregulated in Follicular Thyroid Carcinoma

Frank Weber, Rosemary E. Teresi, Christoph E. Broelsch et al. · The Journal of Clinical Endocrinology & Metabolism · 2006 · 296 citations · Full text

Medicine, Molecular Biology, Oncology +15

Incidence of Finding Residual Disease for Incidental Gallbladder Carcinoma: Implications for Re-resection

Timothy M. Pawlik, Ana Gleisner, Luca Viganò et al. · Journal of Gastrointestinal Surgery · 2007 · 286 citations

Medicine, Radiology, Surgery +14